Mar 23, 2010
The European Drugs Strategy concentrates on demand reduction and supply reduction through international cooperation and research, information and evaluation. However, efforts to provide insight in the different aspects of Europe’s illicit drug problems have largely focused on indicators developed to assess demand-side strategies. The development of measures capturing dimensions of the supply of different illicit substances is an emerging field in the EU. To advance these efforts, the European Commission DG Justice, Freedom and Security commissioned a study to recommend indicators for improving the understanding of illicit drug markets, supply reduction efforts, and drug-related crime in the EU. In this study we reviewed literature and RAND’s previous work in this area, and we gathered insights from European experts and policymakers.
Based on these insights and a conceptual framework for thinking about drug markets, we develop a number of immediate-term, near-term, and long-term recommendations. These recommendations will improve both Member States’ and the European Commission’s ability to monitor drug markets and drug-related crime as well as initiate analyses regarding the effectiveness of supply reduction strategies.
A framework for thinking about drug markets
Indicators for understanding supply-reduction efforts
Indicators for understanding drug-related crime
Insights from three case studies
Creating price series without data: Harnessing the power of forensic data
Summary of major publicly-available datasets on drug supply and drug offences in the EU
Data collected about drug prices, purity and seizures in 3rd countries